You can add location information to your Tweets, such as your city or precise location, from the web and via third-party applications. You always have the option to delete your Tweet location history. Learn more
It’s official: EMA has approved fexinidazole to treat #sleepingsickness!
A doctor’s dream of a simple all-oral cure becomes reality.
Travel to the DRC to discover what #makingmedicalhistory means for doctors and patients:https://www.dndi.org/fexistory
Fexinidazole is the result of our innovative 10-year public-private partnership with @Sanofi & other partners as well as the dedicated efforts of scientists, doctors, health workers, and staff to successfully conduct clinical trials in remote areas of DRC. #makingmedicalhistory
Thank you to our donors including: @gatesfoundation, @DFID_UK, @DutchMFA, @BMBF_Bund, @AFD_en, @giz_gmbh, @francediplo_EN, @MSF, @noradno, Republic & Canton of Geneva, @AECID_es, Swiss Agency for Development & Cooperation, @UBSoptimus, Brian Mercer Charitable Trust & @SNForg
"Fexinidazole is an entirely new chemical entity that has been developed through an alternative non-profit R&D model. It is the first new chemical entity to be developed by DNDi.” - Dr Bernard Pécoul
Read our press release: https://bit.ly/2zX6jfW #makingmedicalhistory
@DNDi, this world of ours needs more of you. It is your work that truly tries to ensure that no one gets left behind, and ensure we achieve our SDGs.
This type of contribution is most important for global health. Institutions in rich countries should focus on medicines and vaccines. @GaviSeth
Great milestone against Neglected Tropical Diseases
Great news, a real breakthrough! Shows usefulness of art 58. Hopefully national regulatory authorities follow swiftly.
Enfin le sommeil peut s'en aller...
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.
